Welcome to our dedicated page for Adlai Nortye Group Ltd. SEC filings (Ticker: ANL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Adlai Nortye Ltd. filings document foreign private issuer reports for a clinical-stage oncology biotechnology company whose securities trade as American depositary shares. The company’s Form 6-K reports include pipeline disclosures for AN9025, AN4035, AN8025, AN4005 and AN0025; clinical and regulatory updates; unaudited financial results; corporate presentations; and material agreements.
ANL filings also record capital-structure matters, including private-placement securities purchase agreements and ADS-to-Class A ordinary share references, as well as shareholder meeting materials, proxy cards, board and committee changes, executive appointments, and the adoption of a share incentive plan.
Adlai Nortye Ltd. - Cormorant Asset Management and Bihua Chen report ownership of 2,897,857 American Depositary Shares, representing 5.19% of the class. The filing states one ADS represents three Class A ordinary shares and references December 31, 2025 outstanding share data.
The statement identifies shared voting and dispositive power over the 2,897,857 ADS and notes a Form 20-F and a Form 6-K cited for outstanding share and private placement figures.
Adlai Nortye Ltd. files a Schedule 13G/A reporting beneficial ownership of 4,561,077 ordinary shares. The filing states this holding represents 2.9% of the issuer's ordinary shares based on April 10, 2026 outstanding counts. The calculation references 142,241,572 Class A and 16,990,000 Class B ordinary shares outstanding as of that date, and attributes sole voting and dispositive power over the 4,561,077 shares to JIN YIN (BVI) LIMITED with a chain of indirect ownership through related entities and Shijun Feng.
Adlai Nortye Ltd. executive Tang Kaiyang, President of Adlai Nortye USA Inc., reported indirect holdings of stock options in the company. These options are held through Nortye International Limited and are exercisable into Class A Ordinary Shares at exercise prices of $2.20, $1.80, and $1.10 per share, with expiration dates ranging from September 2030 to April 2032. The filing updates the structure and terms of these option positions rather than recording new purchases or sales.
Adlai Nortye Ltd. director Ji Ping filed an amended initial ownership report detailing indirect option holdings in the company’s Class A Ordinary shares through Nortye International Limited. The filing lists multiple option positions with exercise prices between 1.1000 and 2.2000 and expiration dates ranging from 2030 to 2032.
Each option series covers a specific number of underlying Class A Ordinary shares, such as 25,000 shares at an exercise price of 2.2000 expiring on 2032-04-01 and 63,063 shares at an exercise price of 1.1000 expiring on 2030-09-08. The entries are characterized as holdings rather than new purchases or sales.
Adlai Nortye Ltd. executive Tang Kaiyang filed an initial Form 3 disclosing indirect holdings of employee stock options on the company’s Class A Ordinary Shares. The filing lists several option grants held through an ESOP, with exercise prices of $1.80 and $1.10 per share and expiration dates in 2030. These entries are reported as holdings rather than new purchases or sales, establishing a baseline view of this officer’s existing derivative position in the stock.
Adlai Nortye Ltd. director Ji Ping has filed a Form 3 insider report for issuer ANL. The filing data identifies Ji Ping as a director and shows no reported transactions, share acquisitions or dispositions, and no derivative positions in the summarized period.
Adlai Nortye Ltd. files Amendment No. 2 to its Form F-3 registration statement (File No. 333-294173) dated April 24, 2026 to furnish legal opinions as Exhibits 5.1 and 23.3 and to update Part II exhibit indexing and signatures. The prospectus in Part I remains unchanged.
Adlai Nortye Ltd. is registering a shelf of up to $600,000,000 of securities and registration for resale of up to 98,577,627 Class A ordinary shares (represented by 32,859,209 ADSs) by selling shareholders.
The prospectus states the company will not receive proceeds from sales by the selling shareholders; the offering may include ADSs, ordinary shares, debt securities, warrants, rights and units and may be sold on Nasdaq or in private transactions. The filing discloses recent private placements that raised approximately $140.0M in February 2026 and $150.0M in April 2026 and lists Nasdaq last sale price of $16.60 per ADS as of April 20, 2026.
Adlai Nortye Ltd. entered into a Securities Purchase Agreement for a private placement of its equity. The company agreed to sell up to 33,962,265 Ordinary Shares, equivalent to 11,320,755 ADSs, at a purchase price of $13.25 per ADS (about $4.4167 per Ordinary Share). The deal is conducted under a private offering exemption and includes customary closing conditions, legal opinions, lock-up agreements from executives and key shareholders, and detailed investor representations. Purchasers receive registration rights requiring Adlai Nortye to file and seek effectiveness of a resale registration statement within defined deadlines so investors can later resell their shares in the public market.